UNSPSC 51352203: Chlorotrianisene

This classification denotes a non-steroidal estrogen with the molecular formula C23H21ClO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6V5034L121, chemically known as 1,1,1-(1-chloro-1-ethenyl-2-ylidene)-tris(4-methoxybenzene) but generally known as chlorotrianisene, which bears US NIH Compound Identifier 11289. European Medicines Agency schedules Chlorotrianisene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06199MIG.

UNSPSC 51352203 Chlorotrianisene is a Commodity code identifying a synthetic estrogen pharmaceutical compound used in hormone replacement and related medical applications. State and local governments procure this drug primarily through public health departments, correctional health systems, and hospital networks to support inmate healthcare, emergency-department protocols, and clinical treatment programs. The code sits within the broader pharmaceutical supply chain and appears in solicitations issued by state departments of health, county jails and prisons, and municipal or regional hospital systems seeking to stock formularies or fulfill standing medical orders.

The source provides no recent state or local contract opportunities under this code, making current market activity visibility limited. Without posted RFPs, RFQs, or IFBs naming this commodity, geographic concentration and representative recent buys cannot be determined from available data. Firms pursuing chlorotrianisene sales to state and local healthcare and correctional buyers should monitor state pharmacy cooperative purchasing catalogs, state health-department formulary updates, and correctional health RFPs for demand signals, as procurement of specialized pharmaceuticals often flows through established group purchasing organizations or standing master agreements rather than individual competitive solicitations.